+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Capricor Therapeutics - logo

Capricor Therapeutics focuses on the discovery, development, and commercialization of novel therapeutics primarily for the treatment of cardiovascular diseases. The company's development stage drug candidates for cardiovascular diseases include CAP-1002 and enderitide, which are in Phase II clinical trials. It is also developing Exosomes for the treatment of cardiovascular and non-cardiovascular diseases. The company was founded in 2005 and is headquartered in Beverly Hills, California.

Blood Coagulation Factor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Blood Coagulation Factor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • March 2024
  • 113 Pages
  • Global
From
Exosomes - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Exosomes - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 118 Pages
  • Global
From
Exosome Technologies Global Market Report 2024 - Product Thumbnail Image

Exosome Technologies Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Clotting Factor Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Clotting Factor Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • June 2023
  • 88 Pages
  • Global
From
Blood Factor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Blood Factor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • March 2024
  • 120 Pages
  • Global
From
Cell and Gene Therapies in Rare Disorders - Market Insights, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Cell and Gene Therapies in Rare Disorders - Market Insights, Epidemiology and Market Forecast - 2032

  • Report
  • April 2023
  • 399 Pages
  • Global
From
Subcutaneous Infusion System Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Subcutaneous Infusion System Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • March 2024
  • 117 Pages
  • Global
From
Small Form Factor Subcutaneous Infusion System Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Small Form Factor Subcutaneous Infusion System Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • March 2024
  • 123 Pages
  • Global
From
RNA Delivery Technologies, 2021: Frost Radar Report - Product Thumbnail Image

RNA Delivery Technologies, 2021: Frost Radar Report

  • Report
  • November 2021
  • 40 Pages
  • Global
From
Recombinant Immunotherapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Recombinant Immunotherapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • March 2024
  • 113 Pages
  • Global
From
Duchenne Muscular Dystrophy - Opportunity Assessment and Forecast to 2030 - Product Thumbnail Image

Duchenne Muscular Dystrophy - Opportunity Assessment and Forecast to 2030

  • Report
  • December 2021
  • 83 Pages
  • Global
From
Bone Marrow Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Bone Marrow Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 555 Pages
  • Global
From
Coronavirus Disease 2019 (COVID-19) Analyst Consensus Global Drug Sales Forecast - Q4, 2021 - Product Thumbnail Image

Coronavirus Disease 2019 (COVID-19) Analyst Consensus Global Drug Sales Forecast - Q4, 2021

  • Report
  • December 2021
  • 38 Pages
  • Global
From
Capricor Therapeutics Inc (CAPR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Capricor Therapeutics Inc (CAPR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • January 2024
  • 89 Pages
From
Comprehensive Report on Capricor Therapeutics Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Capricor Therapeutics Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Loading Indicator